Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by ...

Artificial intelligence (AI) is increasingly reshaping diagnostic pathology, with breast pathology representing one of the most advanced and clinically impactful areas of adoption.

Find out how Oxford’s AI tool HyPrevent could identify hidden organ damage from high blood pressure and support a more ...

Abstract: Heart disease remains a leading cause of mortality worldwide, necessitating early and accurate detection to improve patient outcomes. This paper presents a Heart Disease Prediction System ...

UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut decide between inflammation and healing, a process gone awry in Crohn’s disease.

Abstract: This Study will explore how the IoT and machine learning predict heart disease risks through real-time wearable device and sensor data. The Cleveland and Hungarian datasets have relevant ...

A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said. By Gina Kolata In a small, ...

Haley Billey bought an Oura Ring to track her fertility. It arrived the day after she learned she was pregnant. She slipped the $450 titanium band on anyway. Months of worrisome readings on measures ...

A tool developed by the American Heart Association (AHA), proven to accurately predict heart disease risk for Americans, can be applied to the global population, a new study led by NYU Langone Health ...

Researchers at the University of Glasgow have developed a new way to test networks, which they claim is 25,000 times faster than traditional approaches. Shenjia Ding, a research student at the ...

Doctors have been drilled for decades on the four big risks for heart disease, which kills more Americans every year than any other illness. The fearsome foursome: hypertension, smoking, high levels ...

Sam Altman, OpenAI’s CEO and the public face of ChatGPT, has carved out an image for himself as one of the preeminent AI whisperers of our age, whose influence supposedly extends to the White House on ...